none

PRELIMINARY BID FOR AUSSIE CANCER DRUG

01-03-2018
by 
in 

International pharmaceuticals company Merck has made an aquisition bid for Aussie firm Viralytics, after their drug Cavatak showed promising results in preliminary treatments. 

Viralytics CEO Malcolm McColl said the drug was actually a type of common cold virus that had been found to kill cancer cells, and that Cavatak was most effective when used in conjunction with Merck's immune-boosting drug Keytruda.

As a company, Viralytics centers is research around the development and commercialisation of treatments that harness the power of specific viruses to infect and kill cancer cells.

"The way we tackle cancer now is quite different to ten years ago," said McColl.

"People are looking to turn the patient's immune system against the cancer and that's really what Cavatak is doing."

Even before completion of the bid, trials have begun for testing Cavatak with Merck's Keytruda to treat melanoma, prostate, lung and bladder cancers.

Investors and the Viralytics board have positive views on the bid, viewing it as a strong opportunity for the Australian-based Viralytics to expand its reach and impact. 

"It's a good deal but we have done the hard yards on this company," said Troy Cairns, director of Viralytics investor Quest. 

"It's valuable, but its not easy to to commercialise things in Australia, and Merck is a good partner."

"Merck has done a lot of diligence on the program both in terms of the clinical and manufacturing data and are obviously fully satisfied and convinced that there's a great potential for Cavatak to help cancer patients," Mr McColl said.

 

Related news & editorials

  1. 17.01.2019
    17.01.2019
    by      In
    Despite an increased global focus on IoT security, the latest report from security specialist Gemalto reveals that only around half (48%) of businesses can detect if any of their IoT devices suffers a breach. “The state of IoT security” also finds that the proportion of companies’ IoT budgets spent... Read More
  2. 17.01.2019
    17.01.2019
    by      In
    Online entries for the Australian Packaging and Processing Machinery Association Awards of Excellence will close on 26th January, with judging set to begin on 28th January. The award winners will be announced at the Gala Awards Ceremony on 27th March.
    According to APPMA Chairman Mark Dingley, “... Read More
  3. 17.01.2019
    17.01.2019
    by      In
    A group of almost 30 global companies from the plastics and consumer goods sectors have come together to form the Alliance to End Plastic Waste (AEPW), committing more than $1.0 billion with the goal of investing $1.5 billion over the next five years to help end plastic waste in the environment.... Read More
  4. 15.01.2019
    15.01.2019
    by      In
    Available now from technology distributor Avnet, the January 2019 issue of Supply Chain Navigator looks at some of the operational strategies and technology implementations leading supply chain organisations are using to innovate and grow amid increasingly unpredictable economic conditions.... Read More